•  
  •  
 

Document Type

Original Study

Abstract

Extreme Acute Respiratory disaster SARS-CoV-2, a pathogenic and highly transmissible coronavirus, is the cause of Coronavirus Disease 19 (COVID-19). A significant number of individuals lost their lives as a consequence of the SARS-CoV-2 global pandemic. Despite enormous efforts made in practically every country since its first report in December 2019, this disease spread globally, especially in most of Europe, Iran, and the United States. The spread of SARS-CoV-2 has created a major threat to world health. This study examined several indicators of hormonal parameters in an effort to assessment the collected scientific data and demonstrate the effect of COVID-19 on female fertility. Out of the 180 patients, 110 were infertile and 70 were fertile COVID-19-positive female patients who were admitted to the Kamal al-Samarrai and Fatima Al-Zahraa hospitals in Baghdad between April 2022 and November 2022. The control group consisted of 70 patients. The results of the study showed that there was a statistically significant (anti Müllerian hormone (AMH) between the patient and control groups. Follicular stimulating hormone (FSH), luteinizing hormone (LH) were statistically significant differences and showed elevated level between the patient and control groups. The results showed that COVID-19 infection may alter AMH levels, reduce ovarian reserve, affect the immune system, and potentially alter the course of reproduction. Pituitary gonadotropin and ovarian hormone secretion also seem to be impacted by COVID-19 disease.

Keywords

SARS-CoV2; COVID-19; Fertility; ovarian reserve ; ACE2 ; ovarian hormone

Download

Share

COinS